Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bird

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2012
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe diseaseSongtao Li, Baodong Sun, Mats I Nilsson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type IIBaodong Sun, Haoyue Zhang, Luis M Franco, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2026
Exome Sequencing Reveals rare Loss-of-Function Mutations in FLG and Immune Genes in Multi-Food Allergic PatientsAnas M Khanshour, Cynthia Haddad, Steve Meregini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2014
Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe diseaseBenjamin L Farah, Lauran Madden, Songtao Li, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2019
Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergyBenjamin C Remington, Tanja Krone, Edwin H Kim, et al.
Human Gene Therapy|November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockadeSang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2016
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IADustin J Landau, Elizabeth Drake Brooks, Pablo Perez-Pinera, et al.
Allergy|October 21, 2025
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old ChildrenNeel Singh, Janelle Kesselring, Jess Humphrey, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitizationEdwin H Kim, J Andrew Bird, Michael Kulis, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 21, 2012
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe diseaseSongtao Li, Baodong Sun, Mats I Nilsson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type IIBaodong Sun, Haoyue Zhang, Luis M Franco, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2026
Exome Sequencing Reveals rare Loss-of-Function Mutations in FLG and Immune Genes in Multi-Food Allergic PatientsAnas M Khanshour, Cynthia Haddad, Steve Meregini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2014
Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe diseaseBenjamin L Farah, Lauran Madden, Songtao Li, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2019
Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergyBenjamin C Remington, Tanja Krone, Edwin H Kim, et al.
Human Gene Therapy|November 11, 2014
Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockadeSang-oh Han, Songtao Li, Elizabeth D Brooks, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2016
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IADustin J Landau, Elizabeth Drake Brooks, Pablo Perez-Pinera, et al.
Allergy|October 21, 2025
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old ChildrenNeel Singh, Janelle Kesselring, Jess Humphrey, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitizationEdwin H Kim, J Andrew Bird, Michael Kulis, et al.
Pageof 14